Credit Suisse’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-58,085
| Closed | -$362K | – | 3521 |
|
|
2019
Q2 | $362K | Buy |
+58,085
| New | +$362K | ﹤0.01% | 2955 |
|
|
2018
Q2 | – | Sell |
-4,658
| Closed | -$50K | – | 3609 |
|
|
2018
Q1 | $50K | Buy |
4,658
+118
| +3% | +$1.27K | ﹤0.01% | 3450 |
|
|
2017
Q4 | $191K | Sell |
4,540
-472
| -9% | -$19.9K | ﹤0.01% | 3258 |
|
|
2017
Q3 | $276K | Buy |
5,012
+2,858
| +133% | +$157K | ﹤0.01% | 3299 |
|
|
2017
Q2 | $399K | Buy |
2,154
+187
| +10% | +$34.6K | ﹤0.01% | 2923 |
|
|
2017
Q1 | $235K | Sell |
1,967
-2,550
| -56% | -$305K | ﹤0.01% | 3217 |
|
|
2016
Q4 | $450K | Buy |
4,517
+484
| +12% | +$48.2K | ﹤0.01% | 3144 |
|
|
2016
Q3 | $451K | Buy |
4,033
+2,299
| +133% | +$257K | ﹤0.01% | 3142 |
|
|
2016
Q2 | $178K | Buy |
+1,734
| New | +$178K | ﹤0.01% | 3601 |
|
|
2015
Q4 | – | Sell |
-4,615
| Closed | -$477K | – | 4095 |
|
|
2015
Q3 | $477K | Buy |
+4,615
| New | +$477K | ﹤0.01% | 3229 |
|